July 24, 2014 10:05 PM ET

Capital Markets

Company Overview of Canaan Partners

Executive Profile

Seth A. Rudnick M.D.

Executive Chairman and Chairman of the Advisory Board, G1 Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 Board Members in 14 different organizations across 21 different industries.

See Board Relationships
65--

Background

Dr. Seth A. Rudnick, M.D., serves as an Executive Chairman of G1 Therapeutics, Inc. since January 7, 2014 and also as its Chairman of the Advisory Board since 2013. Dr. Rudnick has been the Chairman of Liquidia Technologies Inc. since March 11, 2008. He serves as the Chairman of ORTHOCON Inc, Drug Innovation Ventures at Emory (DRIVE) and, Meryx. He has been a Director of Liquidia Technologies, Inc. since 2006, Square 1 Financial Inc. since November 2012, Pozen Inc. since ...

Corporate Headquarters

2765 Sand Hill Road
Menlo Park, California 94025

United States

Phone: 650-854-8092
Fax: 650-854-8127

Board Members Memberships

Former Director
Former Director
Former Chairman and Chief Executive Officer
Director
Director
Former Director
Member of Scientific Advisory Board
Director
Former Director
Director
1999-2006
Former Member of the Scientific Advisory Board
2000-N/A
Former Director and Member of Compensation Committee
2000-N/A
Former Director
2001-N/A
Former Director
2006-N/A
Former Director
2006-Present
Chairman
2008-Present
Chairman of the Board
2011-Present
Director, Chairman of Nominating/Corporate Governance Committee and Member of Audit Committee
2012-Present
Director
2012-Present
Director, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee
2013-Present
Director
2014-Present
Executive Chairman and Chairman of the Advisory Board

Education

BA
The University of Pennsylvania
MD
University of Virginia
Post-Doctoral Training
Yale University
MD
Washington University, St. Louis

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Canaan Partners, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.